Jungla

Jungla, Inc. was a San Francisco precision-medicine informatics startup founded in 2016 by Alexander Colavin and Carlos Araya. Backed by Andreessen Horowitz (a16z) and IndieBio, it built a cloud-based Functional Modeling Platform (FMP), also described as a Molecular Evidence Platform, that combined functional genomics, computational biophysics, cellular engineering, and machine learning to produce auditable predictive models for clinical genetic and genomic variant interpretation. Jungla emerged from stealth in 2018 and was acquired by Invitae Corporation in July 2019 (approximately $59M), where its technology augmented Invitae's Sherloc variant-classification approach. The company is now defunct; its original developer surface (jungla.io) is offline and no public API, documentation, or SDKs survive. This profile is a historical record surfaced from the a16z portfolio; it carries no live developer artifacts.

Jungla is profiled on the APIs.io network. Tagged areas include Company, Precision Medicine, Genomics, Bioinformatics, and Healthcare.

0 APIs
CompanyPrecision MedicineGenomicsBioinformaticsHealthcareMachine-LearningClinical DiagnosticsDefunctAcquired

Source (apis.yml)

apis.yml Raw ↑
aid: jungla
deliveryModel:
  model: unknown
  open_source: false
  commercial: false
  callable_host: false
  label: Delivery model not determined — needs a product licence on record
  confidence: low
  source:
  - none
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/jungla.png
name: Jungla
description: Jungla, Inc. was a San Francisco precision-medicine informatics startup founded in 2016 by Alexander Colavin
  and Carlos Araya. Backed by Andreessen Horowitz (a16z) and IndieBio, it built a cloud-based Functional Modeling Platform
  (FMP), also described as a Molecular Evidence Platform, that combined functional genomics, computational biophysics, cellular
  engineering, and machine learning to produce auditable predictive models for clinical genetic and genomic variant interpretation.
  Jungla emerged from stealth in 2018 and was acquired by Invitae Corporation in July 2019 (approximately $59M), where its
  technology augmented Invitae's Sherloc variant-classification approach. The company is now defunct; its original developer
  surface (jungla.io) is offline and no public API, documentation, or SDKs survive. This profile is a historical record surfaced
  from the a16z portfolio; it carries no live developer artifacts.
url: https://raw.githubusercontent.com/api-evangelist/jungla/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- a16z
- IndieBio
x-tier: stub
x-tier-reason: portfolio-lead
x-status: defunct
x-status-detail: Acquired by Invitae Corporation in July 2019; company wound down
x-acquired-by: Invitae Corporation
x-acquired-date: '2019-07-16'
x-acquired-amount-usd: 59000000
x-founded: '2016'
x-founders:
- Alexander Colavin
- Carlos Araya
x-industry: precision-medicine
x-archive-url: https://jungla.bio/
x-enrichment-note: 'Enrichment pipeline run 2026-07-19 found no live developer surface. Original domain jungla.io is dead;
  jungla.bio is a static memorial page ("Jungla Inc. (2016-2019)"); jungla.com is an unrelated outdoor-kitchen product. No
  OpenAPI, docs portal, SDKs, packages, MCP server, or well-known documents exist to harvest. Sources: GenomeWeb (stealth
  emergence), Crunchbase, PitchBook, Invitae/Jungla acquisition press releases (PRNewswire, SEC 8-K).'
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Precision Medicine
- Genomics
- Bioinformatics
- Healthcare
- Machine-Learning
- Clinical Diagnostics
- Defunct
- Acquired
tags_raw:
- Company
- Precision Medicine
- Genomics
- Bioinformatics
- Healthcare
- Machine Learning
- Clinical Diagnostics
- Defunct
- Acquired
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this
  • find_providersBrowse and filter every provider in the catalog.
  • get_provider_artifactsEvery artifact this provider publishes, grouped by type.
  • get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
  • get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
  • get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
  • get_provider_ratingPRO — composite, band, trend and facet scores.
  • apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
  • resolveTurn a domain, URL or GitHub org into the provider it belongs to.
  • find_cohortsEvery scored population of providers in the catalog.
All 92 tools →

Call it yourself

curl for this page
This provider
curl "https://apis.io/api/v1/providers/jungla"
All providers
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose
curl "https://apis.io/api/v1/providers/jungla/operations?limit=25"
How their score was established
curl "https://apis.io/api/v1/providers/jungla/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no form to fill in. Signing in shares your email address with us — we store it to create your key and to recognise you if you sign in with another provider. See our Privacy Policy and Terms.

A second provider on the same verified email joins the account you already have.